Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species

Medical Mycology

Volumn 49, Issue 1, 2010, Pages 16-25

  Guzel, Ahmet Bari ^a   Ilkit, MacIt ^a   Akar, Tuba ^a   Burgut, Refik ^a   Demir, S Cansun ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Candida albicans; Candida glabrata; CHROMagar Candida; ChromID Candida agar; Polyfungal; Vaginitis

Indexed keywords

AGAR; CHLORAMPHENICOL; CHROMAGAR CANDIDA; CHROMID CANDIDA AGAR; GENTAMICIN; POLYSORBATE 80; SABOURAUD DEXTROSE AGAR; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA COLLICULOSA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GERM TUBE TEST; HUMAN; INCUBATION TEMPERATURE; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; KLUYVEROMYCES MARXIANUS; LACERATION; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; MORPHOLOGY; NONHUMAN; QUESTIONNAIRE; RISK FACTOR; SPECIES IDENTIFICATION; VAGINA CANDIDIASIS; VULVOVAGINITIS; YARROWIA LIPOLYTICA; YEAST;

ADOLESCENT; ADULT; AGAR; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CULTURE MEDIA; FEMALE; HUMANS; MIDDLE AGED; MYCOLOGY; QUESTIONNAIRES; RECURRENCE; RISK FACTORS; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI;

EID: 78650394988     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.497972     Document Type: Article

References (33)

1. Nyirjesy P, Sobel JD. Vulvovaginal candidiasis. O bstet Gynecol Clin North Am 2003; 30: 671-684.
2. Goldacre MJ, Watt B, Loudon N, et al. Vaginal microbial fl ora in normal young women. Br Med J 1979; 1: 1450-1453.
3. Sobel JD. Vulvaginal candidiasis. L ancet 2007; 3 69: 1961-1971.
4. Sobel JD, Faro AS, Force RV, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203-211.
5. Nyirjesy P, Seeney SM, Grody MHT, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol 1995; 173: 820-823.
6. Chatwani AJ, Mehta R, Hassan S, et al. Rapid testing for vaginal yeast detection: a prospective study. Am J Obstet Gynecol 2007; 196: 309-310.
7. Pincus DH, Orenga S, Chatellier S. Yeast identifi cation: past, present, and future methods. Med Mycol 2007; 45: 97-121.
8. Freydi é re AM, Guinet R, Boiron P. Yeast identifi cation in the clinical microbiology laboratory: phenotypical methods. Med Mycol 2001; 39: 9-33.
9. Ozcan K, Ilkit M, Ates A, Tura ç -Bi ç er A, Demirhindi H. Performance of Chromogenic Candida agar and CHROMagar Candida in recovery and presumptive identifi cation of monofungal and polyfungal vaginal isolates. Med Mycol 2010; 48: 29-34.
10. Sobel JD, Vazquez JA. Symptomatic vulvovaginitis due to fl uconazole- resistant Candida albicans in a female who was not infected with human immunodefi ciency virus. Clin Infect Dis 1996; 22: 726-727.
11. Eraso E, Moragues MD, Villar-Vidal M, et al. Evaluation of the new chromogenic medium Candida ID2 for isolation and identifi cation of Candida albicans and other medically important Candida species. J Clin Microbiol 2006; 44: 3340-3345.
12. Eraso E, Sahand ID, Villar-Vidal M, et al. Usefulness of Candida ID2 agar for the presumptive identifi cation of Candida dubliniensis . Med Mycol 2006; 44: 611-615.
13. Willinger B, Hillowoth C, Selitsch B, Manafi M. Performance of Candida ID, a new chromogenic medium for presumptive identifi - cation of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol 2001; 39: 3793-3795.
14. Fricker-Hidalgo H, Orenga S, Lebeau B, et al. Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identifi cation of some yeast species. J Clin Microbiol 2001; 39: 1647-1649.
15. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identifi cation of clinically important Candida species. J Clin Microbiol 1994; 32: 1923-1929.
16. Beighton D, Ludford R, Clark DT, et al. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol 1995; 33: 3025-3027.
17. Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans , Candida tropicalis , Candida krusei , and Candida ( Torulopsis ) glabrata . J Clin Microbiol 1996; 34: 58-61.
18. Bouchara JP, Declerck P, Cimon B, e t al. Routine use of CHROMagar Candida medium for presumptive identifi cation of Candida yeast species and detection of mixed polyfungal populations. Clin Microbiol Infect 1996; 2: 202-208.
19. Anson JJ, Allen KD. Evaluation of CHROMagar Candida medium for the isolation and direct identifi cation of yeast species from the female genitale tract. Br J Biomed Sci 1997; 54: 237-239.
20. Willinger B, Manafi M. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses 1999; 42: 61-65.
21. Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray KK. Presumptive identifi cation of Candida species other than C. albicans , C. krusei , and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob 2006; 5: 1.
22. Buckley HR. Identifi cation of yeasts. In: Evans EGV, Richardson MD (eds). Medical Mycology: A Practical Approach . Oxford: IRL Press. 1989: 97-109.
23. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans . J Clin Microbiol 1998; 36: 2093-2095.
24. Donders GG, Prenen H, Verbeke G, Reybrouck R. Impaired tolerance for glucose in women with recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2002; 187: 989-993.
25. Nickerson WJ. Reduction of inorganic substances by yeasts. I. Extracellular reduction of sulfi te by species of Candida . J Infect Dis 1953; 93: 45-56.
26. Pagano J, Levine JD, Trejo W. Diagnostic medium for differentiation of species of Candida. Antibiot Ann 1957 - 1958; 5:137-143.
27. Spinillo A, Capuzzo E, Gulminetti R, et al. Prevalence of and risk factors for fungal vaginitis caused by non- albicans species. Am J Obstet Gynecol 1997; 176: 138-141.
28. Richter SS, Galask RP, Messer SA, et al. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases . J Clin Microbiol 2005; 43: 2155-2162.
29. Sobel JD, Chaim W. Treatment of T orulopsis glabrata vaginitis: a retrospective review of boric acid therapy. Clin Infect Dis 1997; 24: 649-652.
30. Donders GG, Mertens I, Bellen G, Pelckmans S. Self-elimination of risk factors for recurrent vaginal candidosis. Mycoses DOI: 10.1111/ j.1439-0507.2009.01754.
31. Pirotta MV, Gunn JM, Chondros P. Not thrush again! Women s experience of post-antibiotic vulvovaginitis. Med J Aust 2003; 179: 43-46.
32. Bluestein D, Rutledge C, Lumsden L. Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV). Fam Pract Res J 1991; 11: 319-326.
33. Glover DD, Larsen B. Relationship of fungal vaginitis therapy to prior antibiotic exposure. Infect Dis Obstet Gynecol 2003; 11: 157-160.